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Abstract
Aims/hypothesis. Coffee contains several substances
that may affect glucose metabolism. The aim of this
study was to evaluate the relationship between habitu-
al coffee consumption and the incidence of IFG, IGT
and type 2 diabetes.
Methods. We used cross-sectional and prospective
data from the population-based Hoorn Study, which
included Dutch men and women aged 50–74 years.
An OGTT was performed at baseline and after a mean
follow-up period of 6.4 years. Associations were ad-
justed for potential confounders including BMI, ciga-
rette smoking, physical activity, alcohol consumption
and dietary factors.
Results. At baseline, a 5 cup per day higher coffee
consumption was significantly associated with lower
fasting insulin concentrations (−5.6%, 95% CI −9.3 to
−1.6%) and 2-h glucose concentrations (−8.8%, 95%
CI −11.8 to −5.6%), but was not associated with lower
fasting glucose concentrations (−0.8%, 95% CI −2.1
to 0.6%). In the prospective analyses, the odds ratio
(OR) for IGT was 0.59 (95% CI 0.36–0.97) for 3–4
cups per day, 0.46 (95% CI 0.26–0.81) for 5–6 cups
per day, and 0.37 (95% CI 0.16–0.84) for 7 or more
cups per day, as compared with the corresponding val-
ues for the consumption of 2 or fewer cups of coffee
per day (p=0.001 for trend). Higher coffee consump-
tion also tended to be associated with a lower inci-
dence of type 2 diabetes (OR 0.69, CI 0.31–1.51 for
≥7 vs ≤2 cups per day, p=0.09 for trend), but was not
associated with the incidence of IFG (OR 1.35, CI
0.80–2.27 for ≥7 vs ≤2 cups per day, p=0.49 for
trend).
Conclusions/interpretation. Our findings indicate that
habitual coffee consumption can reduce the risk of
IGT, and affects post-load rather than fasting glucose
metabolism.
Keywords Coffee · IFG · IGT · Insulin · Prospective
study · Type 2 diabetes.
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Introduction
Coffee is among the most widely consumed beverages
in the world. Various potential health effects of coffee
have been extensively studied [1, 2, 3, 4, 5, 6], but
data on habitual coffee consumption and the develop-
ment of type 2 diabetes have only recently been pub-
lished [7, 8, 9, 10, 11, 12, 13]. Coffee contains several
substances that affect glucose metabolism. Coffee is a
major source of caffeine and chlorogenic acid [14],
and contains substantial amounts of magnesium and
other micronutrients. Chlorogenic acid is a phenol that
may reduce hepatic glucose output through inhibition
of glucose-6-phosphate hydrolysis [15, 16]. Roasting
of coffee can transform some of the chlorogenic acid
into quinides, which have been shown to enhance in-
sulin action in rats [17]. Caffeine acutely lowered in-
sulin sensitivity [18, 19, 20, 21, 22] and increased glu-
cose concentrations [23, 24, 25, 26, 27] in short-term
metabolic studies in humans. However, these effects
may not persist during chronic coffee consumption
[19], and beneficial effects of caffeine on insulin sen-
sitivity [28] and glucose-induced insulin secretion
[29] have also been suggested. In several cohort stud-
ies, magnesium intake was associated with a lower
risk of type 2 diabetes [30, 31, 32], and in intervention
studies, pharmacological doses of magnesium im-
proved glucose metabolism [33].
Knowledge of both the adverse and beneficial
health effects of coffee consumption is necessary to
permit prioritisation of public health initiatives and to
allow individuals to make informed choices regarding
coffee consumption. In addition, information on the
possible beneficial health effects of specific con-
stituent compounds in coffee may lead to the develop-
ment of coffees or other products with increased con-
tents of these substances. Dutch [7], US [11], Swedish
[10] and Finnish [12, 13] cohort studies have reported
that higher coffee consumption is associated with a
lower risk of type 2 diabetes. Because these studies
only included diagnosed diabetes as an endpoint, they
provided little insight into the pathways through
which coffee consumption may affect the develop-
ment of type 2 diabetes. In addition, it has been 
suggested that detection bias may have affected the re-
sults of studies on coffee and clinical type 2 diabetes
[9]. We therefore examined the relationship between
coffee consumption and the incidence of IFG, IGT
and type 2 diabetes, as assessed by repeated OGTTs,
in the Hoorn Study. We also investigated possible
cross-sectional associations between coffee consump-
tion and different markers of insulin sensitivity and
glucose metabolism.
Subjects, materials and methods
Study population and design. The Hoorn Study is a population-
based cohort study on glucose intolerance in older Dutch men
and women [34]. Baseline data were collected from October
1989 through December 1991. Participants were men and
women aged 50–74 years who were randomly selected from
the municipal registry of the medium-sized town of Hoorn.
The participation rate was 71% and, after exclusion of non-
Caucasians (n=56) and persons with known diabetes (n=90),
2394 participants remained. We excluded participants with
missing information for fasting glucose concentrations (n=4),
coffee consumption or any of the examined potential con-
founders (n=112), leaving 2280 persons in the baseline analy-
ses.
Between January 1996 and December 1998, 2086 partici-
pants were invited to attend a follow-up examination. The oth-
er members of the original cohort were not invited for logistic
reasons (n=140), or because they had died (n=150) or had
moved out of Hoorn (n=108). A total of 1513 persons (72.5%)
participated in the follow-up measurements, and we obtained
complete information on glucose tolerance status at follow-up
for 1479 of these subjects. We excluded those who had known
or newly detected diabetes at baseline (n=132), or missing in-
formation on coffee consumption or any of the examined po-
tential confounders (n=38). As a result, the present prospective
analysis included 1312 participants. The average time between
the baseline and the follow-up measurement was 6.4 years.
The Hoorn Study was approved by the Ethical Review Com-
mittee of the Vrije University Medical Centre and informed
consent was obtained from all participants.
Assessment of outcome parameters. Oral glucose tolerance
tests (OGTT) were performed between 8.00 and 10.00 hours.
Participants were instructed to abstain from alcohol from 17.00
hours and to fast (except for drinking water) from 22.00 hours
on the previous evening. If instructions had not been followed,
or in case of fever or an unusual physical activity pattern the
previous 3 days, the OGTT was postponed. Blood samples
were collected before and 2 h after a glucose load consisting of
75 g glucose anhydrate in 300 ml of water ingested over the
course of 5 min. Laboratory analyses were conducted at the
Vrije University Medical Centre. Serum proinsulin and 2-h in-
sulin concentrations were only determined in a random sample
taken within strata for sex, age and glucose tolerance [34].
Plasma glucose was determined directly, and serum was stored
at −20°C for the determination of insulin and proinsulin con-
centrations. Glucose was measured using a glucose dehydroge-
nase method (Merck, Darmstadt, Germany). Immuno-specific
insulin was measured in serum by a double-antibody RIA (an-
tibody SP21; Linco Research, St. Louis, Mo., USA). Proinsu-
lin was measured by a double-antibody RIA, based on reagents
from R. Bowsher (Lilly Laboratory for Clinical Research, Indi-
anapolis, Ind., USA). The inter-assay analytical CV was 1.4%
for glucose and 6% for insulin levels within the range of
40–1000 pmol/l (lower limit of sensitivity 12 pmol/l), and 6%
(at 100 pmol/l) to 15% (at lower levels) for proinsulin (lower
limit of sensitivity 3 pmol/l). Fasting glucose and insulin con-
centrations were used to calculate the homeostasis model as-
sessment index for insulin resistance (HOMA-IR) as described
by Matthews et al. [35]. Normal fasting glucose, normal glu-
cose tolerance, IFG, IGT and diabetes were defined according
to the 1999 criteria of the World Health Organization [36].
Assessment of coffee consumption and potential confounders.
We used a 92-item semi-quantitative food-frequency question-
naire to assess average food intake, including alcohol and cof-
fee consumption. This instrument included the questions
“How often do you usually drink coffee?” (11 answer cate-
gories) and “How much coffee do you drink on average on
such a day?” (where the answer was provided in terms of cups
consumed and, according to the Dutch definition, one cup is
equivalent to 125 ml). In addition, specific questions were
asked about addition of milk or cream to coffee, and the addi-
tion of sugar (or honey or syrup) to coffee, tea, yoghurt or
curds, porridge, and breakfast cereals. The questionnaire was
completed by the participants at home and was subsequently
checked during an interview at the research centre. Nutrient
intake was calculated using a computerised version of the
Dutch Food Composition Table [37]. This questionnaire was
validated by comparison with a dietary history interview that
was conducted in 74 male and female inhabitants of Hoorn at
home by a dietician [37]. Pearson correlation coefficients for
estimates from the questionnaire and the dietary history were
0.73 for saturated fat (g), 0.68 for polyunsaturated fat (g), and
0.70 for fibre intake (g).
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Results
Baseline data. The median habitual coffee consump-
tion of this population was 4 cups per day (interquar-
tile range 3–6 cups per day). Persons with a higher
coffee consumption were more likely to be men and to
smoke, and were less likely to use antihypertensive
medication and to drink tea (Table 1). In addition,
higher coffee consumption was associated with lower
age and fibre intake, and higher alcohol and magne-
sium intake. Of the coffee drinkers, 43.7% used sugar
in their coffee.
Post-load plasma glucose concentrations decreased
with increasing levels of coffee consumption in a step-
wise manner, and adjustment for potential con-
founders did not materially change this association
(Table 2). Compared with the consumption of two
cups of coffee or fewer per day, lower multivariate-ad-
justed 2-h post-load glucose concentrations were 
observed for the consumption of 3–4 cups per day 
(−0.52 mmol, 95% CI −0.81 to −0.23 mmol/l), 4–5
cups per day (−0.76 mmol/l, 95% CI −1.07 to 
−0.43 mmol/l) and 7 cups or more per day 
(−0.87 mmol/l, 95% CI −1.29 to −0.45 mmol/l). When
coffee consumption was analysed as a continuous
variable using a multivariate model, a 5 cup per day
higher consumption was associated with an 8.8% re-
duction in 2-h glucose concentration (Table 2). This
inverse association remained essentially the same after
further adjustment for magnesium intake (−9.3% per
additional 5 cups per day) or added sugar intake 
(−8.4% per additional 5 cups per day). We examined
the robustness of the association between coffee con-
sumption and 2-h glucose concentrations in analyses
excluding persons with cardiovascular diseases or us-
ing antihypertensive medication, coffee abstainers,
users or non-users of milk in coffee, and users or non-
users of sugar in coffee, and by analyses within strata
by sex, age (<60 or ≥60 years), overweight (<25 or
≥25 kg/m2), current smoking (yes or no), physical ac-
tivity (score <6 or ≥6), and alcohol consumption (yes
or no). The inverse association between coffee con-
sumption and 2-h glucose concentrations remained in
all these analyses (all p<0.05, range −6.0 to −11.0%
per additional 5 cups per day).
We also examined whether coffee consumption was
associated with other markers of insulin sensitivity
and glucose metabolism (Table 2). Coffee consump-
tion was significantly inversely associated with fasting
and 2-h insulin concentrations and HOMA-IR values,
whereas the inverse associations between coffee con-
sumption and fasting glucose and proinsulin concen-
trations were not statistically significant. Tea con-
sumption was inversely associated with fasting glu-
cose concentrations (−0.5%, 95% CI −0.8 to −0.2%
per cup per day, adjusted for coffee and the variables
included in the multivariate model used for the coffee
analysis), but was not significantly associated with
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Physical activity was assessed by the same questionnaire as
used in the Zutphen Elderly Study, with slight modifications
[38]. A score was calculated (1 point per activity, range 0–9)
based on involvement (yes or no) in sports, cycling, gardening,
walking, odd jobs, climbing staircases at home, household ac-
tivities, work and daily food shopping. Information on history
of cardiovascular diseases was obtained using a questionnaire
based on the Rose questionnaire [39]. Cigarette smoking habits
and medication use were also assessed by questionnaire.
Height and weight were measured without shoes and outer gar-
ments, and BMI was calculated as weight (kg) divided by
height squared (m2). Waist circumference was measured at the
level midway between the lowest rib margin and the iliac crest,
and hip circumference was measured at the widest level over
the greater trochanters. WHR was calculated as waist circum-
ference divided by hip circumference.
Statistical analysis. Statistical analyses were carried out using
SAS software (SAS Institute, Cary, N.C., USA). We used
multivariate linear regression analysis to examine associations
between coffee consumption and markers of glucose metabo-
lism and insulin sensitivity at baseline. As outcome variables
were not normally distributed (except for 2-h glucose), we
logarithmically transformed these variables to correspond
with the assumptions for regression analysis. Regression coef-
ficients were re-transformed and expressed as percentage 
difference in dependent variables for a defined difference in
coffee consumption (5 cups per day: the difference between
the 10th and 90th percentile of coffee consumption). We cal-
culated adjusted differences in 2-h glucose concentrations ac-
cording to categories of coffee consumption using analysis of
covariance.
For the prospective data, we performed logistic regression
analysis to calculate odds ratios (ORs) and 95% confidence in-
tervals. The analyses included participants without diabetes at
baseline for incidence of type 2 diabetes (n=1312), participants
with normal glucose tolerance at baseline and without diabetes
at follow-up for incidence of IGT (n=1117), and participants
with normal fasting glucose at baseline and without diabetes at
follow-up for incidence of IFG (n=1116). We used the same
categories of coffee consumption as those defined in a previ-
ous study on coffee consumption and type 2 diabetes [7]. We
combined the upper two categories for analyses stratified by
sex to avoid imprecise estimates due to low numbers. The mul-
tivariate model included covariables that were entered as con-
tinuous variables (age, BMI, WHR, physical activity score,
and intake of total energy, fibre, saturated fat and polyunsatu-
rated fat), and variables that were entered as dichotomous
dummy variables for each category except for the reference
category (sex, alcohol consumption [none, ≤10, 10–30 or
>30 g/day], cigarette smoking [never, past or current], history
of cardiovascular diseases [yes or no] and use of antihyperten-
sive medication [yes or no]). We conducted additional analyses
with adjustment for added sugar intake (g/day) and magnesium
intake (mg/day). Magnesium intake was not adjusted to correct
for confounding, but rather to examine whether the magnesium
supplied by coffee explained the association between coffee
consumption and glucose tolerance. We also examined associa-
tions between tea consumption and parameters of glucose me-
tabolism, because tea is also a source of caffeine and phenolic
compounds with antioxidant activity. Saturated and polyunsat-
urated fat intakes were expressed as percentages of total ener-
gy intake. Fibre and magnesium intakes were adjusted for total
energy intake using the residual method [40]. The p values for
trend were calculated by modelling coffee consumption as a
continuous variable. All p values were two-sided, and a p val-
ue less than 0.05 was considered statistically significant.
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any of the other parameters presented in Table 2 (data
not shown).
Prospective data. As shown in Table 3, higher coffee
consumption was associated with a lower incidence
of IGT (incidence 17.2% for ≤2 cups per day, 6.5%
for ≥7 cups per day). This inverse association re-
mained after multivariate adjustment for potential
confounders (OR 0.37, 95% CI 0.16–0.84 for ≥7 vs
≤2 cups per day, p=0.001 for trend), and was similar
for men and women (OR 0.44 for men, 0.42 for
women for ≥5 cups per day vs ≤2 cups per day).
Higher coffee consumption also tended to be associ-
ated with a lower incidence of type 2 diabetes (OR
0.69, 95% CI 0.31–1.51 for ≥7 vs ≤2 cups per day,
p=0.09 for trend), but was not associated with the in-
cidence of IFG. Additional adjustment for magne-
sium intake (IGT: OR 0.38, 95% CI 0.16–0.90 for ≥7
vs ≤2 cups per day) or added sugar intake (IGT: OR
0.33, 95% CI 0.14–0.78 for ≥7 vs ≤2 cups per day)
did not materially alter the observed associations.
Tea consumption was not significantly associated
Table 1. Baseline characteristics of the Hoorn Study population according to coffee consumption
Coffee consumption (cups per day)
≤2 3–4 5–6 ≥7
(n=487) (n=897) (n=652) (n=244)
Women 63 58 49 40
Age (years) 63.6 (7.56) 62.2 (7.24) 60.0 (6.68) 58.0 (5.97)
BMI (kg/m2) 26.4 (3.74) 26.6 (3.52) 26.4 (3.40) 26.3 (3.19)
WHR
Men 0.96 (0.07) 0.95 (0.07) 0.94 (0.06) 0.94 (0.06)
Women 0.85 (0.07) 0.85 (0.07) 0.84 (0.07) 0.84 (0.08)
Physical activity scorea 5.5 (1.6) 5.7 (1.6) 5.6 (1.5) 5.7 (1.5)
Cigarette smoking 21 23 41 55
Alcohol intake (g/day)
Men 6.2 (1.7–16.6) 8.9 (2.2–17.7) 9.3 (3.8–19.6) 9.7 (2.2–24.3)
Women 0.0 (0.0–5.0) 2.1 (0.0–7.1) 2.2 (0.0–9.3) 3.8 (0.0–9.3)
Saturated fat intake (% energy) 17.2 (3.8) 17.3 (3.3) 17.3 (3.3) 17.5 (3.3)
Polyunsaturated fat intake (% energy) 7.9 (3.3) 8.0 (3.3) 7.9 (3.1) 7.7 (3.2)
Fibre intake (g/day) 27.0 (6.9) 27.2 (6.2) 26.4 (5.9) 25.2 (5.6)
Magnesium intake (mg/day) 272 (59) 284 (54) 292 (51) 306 (51)
Tea drinkers 95 92 80 59
Added sugar intake (g/day) 5.0 (0.0–17.0) 5.0 (0.0–24.0) 9.0 (0.0–36.0) 6.0 (0.0–45.5)
Use of antihypertensive medication 23 22 15 12
Cardiovascular disease 19 19 17 19
Values are medians (interquartile ranges) percentages or means (SD). a range 0–9
Table 2. Baseline data on differences in markers of hyperglycaemia and insulin resistance for an increment in coffee consumption
of 5 cups per day in the Hoorn Study
Marker Age-and sex-adjusted modela Multivariate-adjusted modelb
2-h glucose −9.9% (−13.0 to −6.8%) −8.8% (−11.8 to −5.6%)
Fasting glucose −0.8% (−2.1 to 0.6%) −0.8% (−2.1 to 0.6%)
2-h insulin −21.3% (−32.3 to −8.5%) −19.7% (−30.2 to −8.1%)
Fasting insulin −5.3% (−9.2 to −1.1%) −5.6% (−9.3 to −1.6%)
HOMA-IR −6.0% (−10.4 to −1.4%) −6.3% (−10.4 to −2.1%)
Fasting proinsulin −11.8% (−26.3 to 5.6%) −13.1% (−26.9 to 3.3%)
Values shown are percentage differences (95% CI) per addi-
tional 5 cups per day. Data were complete for fasting glucose
(n=2280). Due to missing values, data are based on n=2270 for
2-h glucose, and n=2229 for fasting insulin and HOMA-IR.
Due to sampling and missing values, data are based on n=589
for 2-h insulin, and n=465 for proinsulin. a Adjusted for age
(years) and sex; b adjusted for age (years), sex, BMI (kg/m2),
WHR, physical activity (score), alcohol consumption (none,
≤10, 10–30 or >30 g/day), cigarette smoking (never, past or
current), history of cardiovascular disease (yes or no), use of
antihypertensive medication (yes or no), and intake of fibre
(g/day), total energy (kJ/day), saturated fat (% energy) and
polyunsaturated fat (% energy)
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with any of the three studied endpoints (data not
shown).
Discussion
In this population-based study of older men and wom-
en, higher habitual coffee consumption was associated
with lower 2-h post-load glucose concentrations and a
lower incidence of IGT. Coffee consumption also
tended to be associated with a lower incidence of type
2 diabetes, but was not associated with fasting glucose
concentrations or the incidence of IFG. These data
suggest that coffee consumption affects post-load
rather than fasting glucose metabolism. Coffee con-
sumption was also cross-sectionally associated with
lower values for markers of insulin resistance. Magne-
sium intake did not explain the observed associations.
Previous studies that reported an inverse associa-
tion between coffee consumption and incidence of
type 2 diabetes only included diagnosed cases [7, 10,
11, 12, 13]. The present study included repeated
OGTTs in all participants; thus, detection bias can be
excluded as a possible explanation for the observed
associations. Misclassification of coffee consumption
is unlikely to have affected the findings, as coffee use
tends to be a constant and well-reported habit [7]. Al-
though the Hoorn Study collected extensive informa-
tion on potential confounders, residual confounding
may have affected the results. However, the consisten-
cy of results across strata by risk factors and across
cohorts in different countries argues against residual
confounding as an explanation for the observed asso-
ciations. Loss to follow-up can bias the results of
prospective studies if it is associated with both the ex-
posure and the outcome of interest. However, coffee
consumption at baseline was similar for both those
who did and did not participate in the follow-up mea-
surements (both groups: median 4.0 cups per day, in-
terquartile range 3.0–6.0 cups per day).
Our findings are consistent with the inverse associ-
ation between coffee consumption and risk of diag-
nosed type 2 diabetes reported by cohort studies per-
formed in a diverse variety of countries [7, 10, 11, 12,
13]. In addition, our results are in agreement with the
observed association between higher coffee consump-
tion and lower prevalences of hyperglycaemia in
Swedish [41], Japanese [42] and Dutch [43] popula-
tions. Conversely, in Pima Indians [9] and in a Finnish
cohort [8] coffee consumption was not associated with
type 2 diabetes. However, the study on Pima Indians
only examined coffee consumption over a narrow
range of values: the highest category of coffee con-
sumption was 3 cups of coffee or more per day [9]. In
addition, possible confounding by lifestyle factors was
not controlled for in this study, which may have
masked an existing association, since high coffee con-
sumption has previously been shown to cluster with
unhealthy behaviour (e.g. smoking, lack of physical
activity, poor diet) in US populations [11]. The lack of
an association in the Finnish study [8] may have been
due to changing habits of coffee consumption in Fin-
land during the long follow-up period or the higher
consumption of boiled as opposed to filter coffee [12].
In the Netherlands, coffee was predominantly paper
filtered [44]. In the present study, the association be-
Table 3. Incidence of type 2 diabetes IGT and IFG according to coffee consumption in the Hoorn Study
Coffee consumption (cups per day)
≤2 3–4 5–6 ≥7 p value for trend
Type 2 diabetes
Cases 11.1% (29/261) 10.3% (52/506) 9.2% (36/392) 7.2% (11/153)
Age- and sex-adjusted OR 1 (referent) 0.95 (0.59–1.55) 0.91 (0.54–1.55) 0.76 (0.36–1.59) 0.11
Multivariate ORa 1 (referent) 0.94 (0.56–1.55) 0.92 (0.53–1.61) 0.69 (0.31–1.51) 0.09
IGT
Cases 17.2% (35/203) 10.7% (46/432) 8.2% (28/343) 6.5% (9/139)
Age- and sex-adjusted OR 1 (referent) 0.60 (0.37–0.96) 0.50 (0.29–0.87) 0.44 (0.20–0.96) 0.005
Multivariate ORa 1 (referent) 0.59 (0.36–0.97) 0.46 (0.26–0.81) 0.37 (0.16–0.84) 0.001
IFG
Cases 24.1% (53/220) 27.1% (115/425) 25.2% (85/337) 31.3% (42/134)
Age- and sex-adjusted OR 1 (referent) 1.18 (0.81–1.73) 1.05 (0.70–1.57) 1.42 (0.87–2.32) 0.31
Multivariate ORa 1 (referent) 1.18 (0.80–1.75) 1.02 (0.67–1.55) 1.35 (0.80–2.27) 0.49
Values shown for cases are % (n/n total). The analysis included
n=1312 without diabetes at baseline for incidence of Type 2 di-
abetes, n=1117 with normal glucose tolerance at baseline and
without diabetes at follow-up for incidence of IGT, and n=1116
with normal fasting glucose at baseline and without diabetes at
follow-up for incidence of IFG. a OR adjusted for age (years),
sex, BMI (kg/m2), WHR, physical activity (score), alcohol
consumption (none, ≤10, 10–30 or >30 g/day), cigarette smok-
ing (never, past or current), history of cardiovascular disease
(yes or no), use of antihypertensive medication (yes or no), and
intake of fibre (g/day), total energy (kJ/day), saturated fat (%
energy) and polyunsaturated fat (% energy)
tween coffee consumption and type 2 diabetes was
weaker than the association between coffee consump-
tion and IGT. This may reflect a difference in the clas-
sification of type 2 diabetes and IGT. The diagnosis of
type 2 diabetes is based on both fasting and post-load
glucose concentrations, whereas IGT is based on post-
load glucose concentrations alone. In our study, post-
load concentrations of glucose were more strongly as-
sociated with coffee consumption than fasting levels.
Alternatively, coffee consumption may have a more
pronounced effect on the early stages of the develop-
ment of type 2 diabetes than on the transition from
IGT to type 2 diabetes. In healthy volunteers, con-
sumption of decaffeinated coffee was associated with
higher glucagon-like peptide-1 secretion following the
oral administration of 25 g glucose [45]. Gut hor-
mones such as glucagon-like peptide-1 affect respons-
es to oral glucose loads [46], and it could be speculat-
ed that these incretins contribute to the pronounced ef-
fect of coffee on post-load glucose concentrations sug-
gested by our study.
Our findings suggest that habitual coffee consump-
tion is associated with increased insulin sensitivity.
This is consistent with the results from a study of
1088 Swedish elderly men [47] in which habitual cof-
fee consumption was associated with increased insulin
sensitivity as measured using a hyperinsulinaemic–
euglycaemic clamp, but not with early insulin re-
sponse during the OGTT (30-min increment of insulin
per 30-min increment of glucose) [47]. In another
Swedish study, coffee consumption was also associat-
ed with a lower HOMA-IR in women, but not in men
[41]. In contrast to these findings, short-term metabol-
ic studies have reported that caffeine acutely lowers
insulin sensitivity [18, 19, 20, 21, 22]. However, the
effects of long-term habitual coffee consumption on
insulin sensitivity may be different from the acute ef-
fects of caffeine. Firstly, caffeine intake acutely in-
creases blood pressure and concentrations of cate-
cholamines, but these effects are attenuated after pro-
longed use of caffeine [48]. It is plausible that the 
adverse effect of caffeine on insulin sensitivity is also
attenuated during chronic use [19]. Secondly, benefi-
cial effects of caffeine and other constituents of coffee
on insulin sensitivity have also been suggested [17,
28], and may only become apparent after prolonged
use of coffee. Longer-term intervention studies exam-
ining the effect of caffeine and coffee consumption on
insulin sensitivity are needed to explain the discrepan-
cy between the findings from cohort studies and short-
term metabolic trials.
We were not able to analyse the effects of coffee
and caffeine intake independently of each other, be-
cause consumption of other sources of caffeine and
decaffeinated coffee [7] was relatively low in older
Dutch populations at the time of the study. In a Japa-
nese study, the inverse association between coffee
consumption and glucose intolerance was stronger for
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coffee than for caffeine intake [42]. In two US co-
horts, the inverse association between coffee con-
sumption and the risk of type 2 diabetes could only be
partly explained by caffeine intake [11]. These results
suggest that coffee components other than caffeine
may also affect glucose metabolism. Coffee contains
many bioactive substances, including magnesium and
the phenol chlorogenic acid. Our findings suggest that
magnesium intake does not explain a substantial part
of the association between coffee consumption and
glucose intolerance. Chlorogenic acid is partly ab-
sorbed by the body [49], and metabolic effects in hu-
mans have been shown [50]. In a study in streptozoto-
cin diabetic rats, oral administration of chlorogenic
acid reduced plasma glucose levels over a 3-h period
[51]. Chlorogenic acid may reduce hepatic glucose
output through inhibition of glucose-6-phosphatase
activity [15], may attenuate glucose absorption rates
by inhibiting the sodium-dependent glucose trans-
porters [14], and may reduce oxidative stress through
its anti-oxidant properties [14]. Roasting of coffee
transforms some chlorogenic acid into quinides, com-
pounds that have been shown to improve insulin sen-
sitivity in rats [17].
In the present study, tea consumption was inversely
associated with fasting glucose concentrations, but
was not substantially associated with other parameters
of glucose metabolism or the incidence of glucose in-
tolerance. These results should be interpreted with
caution, because the effect of tea consumption on glu-
cose metabolism was not the primary hypothesis of
our study. Also, in contrast with coffee consumption,
tea consumption tends to be associated with a more
health-conscious lifestyle, which increases the proba-
bility of confounding. Habitual tea consumption was
shown to be associated with increased insulin sensitiv-
ity in a cross-sectional study [47], but was not associ-
ated with the risk of diagnosed type 2 diabetes in pre-
vious cohort studies [11, 12].
In conclusion, the results of the present study are in
agreement with previous studies on diagnosed diabe-
tes reporting a relationship between habitual coffee
consumption and a lower incidence of glucose intoler-
ance [7, 10, 11, 12, 13]. Our findings were consistent
with a beneficial effect of habitual coffee consumption
on insulin sensitivity, and suggest that coffee con-
sumption affects post-load rather than fasting glucose
metabolism. It is premature to advocate high coffee
consumption as a means of reducing the risk of type 2
diabetes. However, the available data on coffee con-
sumption and glucose metabolism warrant mechanis-
tic studies of coffee constituents and longer-term ran-
domised trials investigating the effects of coffee on in-
sulin sensitivity and glucose tolerance.
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